In GBM, ΔEGFR drives strong Akt activation in the context of PTEN loss, and can drive gliomagenic transformation of Pten−/−; Ink4a/arf−/− astrocytes [6], [45]. This evidence concerns the gene CDKN2A and glioblastoma.